From May 1, 2021 onwards a jab of Serum Institute of India’s (SII) Covishield (AstraZeneca) vaccine will value Rs 600 in a personal hospital. What is fascinating although is that each one those that had acquired (or will obtain) their first jab of Covishield for Rs 250 in a personal hospital throughout this month (April, 2021), will find yourself paying Rs 600 for his or her second dose when it turns into due after the necessary six to eight weeks of interval.
Days after the Centre had introduced its ‘Liberalised Pricing and Accelerated National Covid-19 Vaccination Strategy’ which is able to change into efficient from May 1, and underneath which vaccine producers could be free to produce 50 per cent of their month-to-month doses to state governments and within the open market; SII on Wednesday stated that it’ll promote its Covishield vaccine at Rs 400 per dose to state governments and to non-public hospitals at Rs 600.
The new charges could be relevant from May 1, 2021 when the Centre’s liberalised vaccination technique comes into pressure.
Currently Covishield vaccine prices Rs 250 in non-public hospitals, which is a extremely subsidised price because the Centre has until now been immediately procuring it from SII.
However as soon as the liberalised pricing and vaccination technique turns into relevant, the current dispensation the place non-public Covid vaccination centres (non-public hospitals) obtain doses from Government and cost as much as Rs 250 per dose, will stop to exist.
Also underneath the liberalised pricing and vaccination technique, the Centre has stated that “non-public corporations would provide 50% of their month-to-month Central Drugs Laboratory (CDL) launched doses to Government of India and could be free to provide remaining 50% doses to state governments and within the open market.
In different phrases, states which until now have been now getting the Covishield vaccine via Centre, will from May 1 onwards, procure it immediately from the producer.
As the brand new vaccination technique pointers clearly state that producers must, in a clear method, declare the worth of the vaccine (meant to be provided to states and within the open market) earlier than May 1, subsequently SII introduced its new worth for Covishield at present.
Under the liberalised technique, Centre has opened vaccination for all residents who’re 18 years and above.